4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-19-000188
CIK 0000810509other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:29 PM ET
Size
5.1 KB
Accession
0001437749-19-000188
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2019-01-02$0.00/sh+125,000$125→ 125,000 totalExercise: $0.38Exp: 2029-01-02→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]41,667 options will be exercisable on or after 1/2/2019; 41,667 options will be exercisable on or after 7/2/2019; and 41,666 options will be exercisable on or after 1/2/2020.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:29 PM ET
- Size
- 5.1 KB